Guardant Health
GH
#2480
Rank
A$9.34 B
Marketcap
$75.60
Share price
-5.93%
Change (1 day)
126.67%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company